Phase III NEMO trial and the novel MEK inhibitor Binimetinib

Phase III NEMO trial and the novel MEK inhibitor Binimetinib

AnnualMeeting2016

3 years
911 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Omid Hamid, MD of the Angeles Clinic discusses the phase III NEMO trial and the novel MEK inhibitor Binimetinib
Up Next Autoplay